TY  - GEN
AU  - Fujiwara,Keiichi
AU  - Yokosuka,Osamu
AU  - Komine,Fumihiko
AU  - Moriyama,Mitsuhiko
AU  - Kato,Naoya
AU  - Yoshida,Haruhiko
AU  - Tanaka,Naohide
AU  - Imazeki,Fumio
AU  - Shiratori,Yasushi
AU  - Arakawa,Yasuyuki
AU  - Omata,Masao
TI  - Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1
SN  - 1478-3223
PY  - 2006///1204
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C
KW  - drug therapy
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - RNA, Viral
KW  - blood
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1111/j.1478-3231.2006.01263.x
ER  -